Yellowstone Biosciences Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 29

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $21M

  • Investors
  • 2

Yellowstone Biosciences General Information

Description

Developer of a therapeutic biotechnology platform designed to create highly selective targeted therapies for cancer. The company offers proprietary access to a biobank for samples from acute myeloid leukemia patients, including a rare cohort of high-risk patients cured by allogeneic stem cell transplantation, enabling healthcare firms to identify frequently expressed peptide antigens presented by HLA Class II to transform patient lives.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 4100 Chancellor Court
  • John Smith Drive, ARC Oxford
  • Oxford OX4 2GX
  • England, United Kingdom
Primary Industry
Discovery Tools (Healthcare)
Vertical(s)
Corporate Office
  • 4100 Chancellor Court
  • John Smith Drive, ARC Oxford
  • Oxford OX4 2GX
  • England, United Kingdom

Yellowstone Biosciences Timeline

202420252026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Yellowstone Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 20-Jun-2024 $21M Completed Startup
1. University Spin-Out 20-Jan-2023 Completed Startup
To view Yellowstone Biosciences’s complete valuation and funding history, request access »

Yellowstone Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Yellowstone Biosciences’s complete cap table history, request access »

Yellowstone Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a therapeutic biotechnology platform designed to create highly selective targeted therapies for cancer. The
Discovery Tools (Healthcare)
Oxford, United Kingdom
29 As of 2025

Oxford, United Kingdom
 

Waltham, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Yellowstone Biosciences Competitors (28)

One of Yellowstone Biosciences’s 28 competitors is Exogene, a Venture Capital-Backed company based in Oxford, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Exogene Venture Capital-Backed Oxford, United Kingdom
TScan Therapeutics Formerly VC-backed Waltham, MA
NextCure Formerly VC-backed Beltsville, MD
Adaptimmune Therapeutics Formerly VC-backed Abingdon, United Kingdom
AVM Biotechnology Private Equity-Backed Seattle, WA
You’re viewing 5 of 28 competitors. Get the full list »

Yellowstone Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Yellowstone Biosciences Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Syncona Venture Capital Minority
University of Oxford University Minority
To view Yellowstone Biosciences’s complete investors history, request access »

Yellowstone Biosciences FAQs

  • When was Yellowstone Biosciences founded?

    Yellowstone Biosciences was founded in 2023.

  • Where is Yellowstone Biosciences headquartered?

    Yellowstone Biosciences is headquartered in Oxford, United Kingdom.

  • What is the size of Yellowstone Biosciences?

    Yellowstone Biosciences has 29 total employees.

  • What industry is Yellowstone Biosciences in?

    Yellowstone Biosciences’s primary industry is Discovery Tools (Healthcare).

  • Is Yellowstone Biosciences a private or public company?

    Yellowstone Biosciences is a Private company.

  • What is the current valuation of Yellowstone Biosciences?

    The current valuation of Yellowstone Biosciences is .

  • What is Yellowstone Biosciences’s current revenue?

    The current revenue for Yellowstone Biosciences is .

  • How much funding has Yellowstone Biosciences raised over time?

    Yellowstone Biosciences has raised $21M.

  • Who are Yellowstone Biosciences’s investors?

    Syncona and University of Oxford have invested in Yellowstone Biosciences.

  • Who are Yellowstone Biosciences’s competitors?

    Exogene, TScan Therapeutics, NextCure, Adaptimmune Therapeutics, and AVM Biotechnology are some of the 28 competitors of Yellowstone Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process